NuvOx Pharma, LLC
NuvOx Therapeutics is dedicated to advancing life-saving oxygen therapeutics with a mission to reverse tissue hypoxia, which plays a significant role in various fatal diseases. The company is committed to patient safety and ensuring access to innovative oxygen-based treatments.
Industries
Nr. of Employees
small (1-50)
Products
Intravenous perfluorocarbon emulsion oxygen therapeutic (investigational)
An investigational intravenous perfluorocarbon-based emulsion engineered to form nanodroplets after infusion, facilitating oxygen uptake in the lungs and offloading to hypoxic tissues; under preclinical and clinical evaluation for acute indications including stroke, tumor radiosensitization, respiratory distress/ARDS, myocardial infarction and hemorrhagic shock.
Intravenous perfluorocarbon emulsion oxygen therapeutic (investigational)
An investigational intravenous perfluorocarbon-based emulsion engineered to form nanodroplets after infusion, facilitating oxygen uptake in the lungs and offloading to hypoxic tissues; under preclinical and clinical evaluation for acute indications including stroke, tumor radiosensitization, respiratory distress/ARDS, myocardial infarction and hemorrhagic shock.
Services
Sponsor and coordination of clinical trials
Sponsorship, protocol execution and site coordination for investigator-initiated and company-sponsored clinical trials across neurological, oncological and respiratory indications.
In-house GMP manufacture of investigational medicinal product
Production of investigational intravenous emulsions in a GMP environment with ISO 5 cleanroom capability to support clinical supply and rapid iteration between development and manufacturing.
Government and academic partnership development
Collaboration with public agencies and academic sponsors to obtain grant funding and to enable multi-center clinical trials and preclinical assessment networks.
Sponsor and coordination of clinical trials
Sponsorship, protocol execution and site coordination for investigator-initiated and company-sponsored clinical trials across neurological, oncological and respiratory indications.
In-house GMP manufacture of investigational medicinal product
Production of investigational intravenous emulsions in a GMP environment with ISO 5 cleanroom capability to support clinical supply and rapid iteration between development and manufacturing.
Government and academic partnership development
Collaboration with public agencies and academic sponsors to obtain grant funding and to enable multi-center clinical trials and preclinical assessment networks.
Expertise Areas
- Clinical trial management
- Translational preclinical research
- Neuroprotection and stroke therapeutics
- Oncology radiosensitization and tumor hypoxia reversal
Key Technologies
- Perfluorocarbon emulsion-based oxygen delivery
- Nanodroplet-forming intravenous emulsions
- In vitro oxygen offloading and gas-transfer assays
- Comparative gas solubility and absorption testing